Showing results (341-350 of 675) with videos related to
Sort By:
Pageof 68
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-OophorectomyMeghna S Trivedi, Nadir Arber, Eitan Friedman, et al.The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.Cancer Research|March 22, 2018
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple MyelomaXiaomu Wei, M Nieves Calvo-Vidal, Siwei Chen, et al.JAMA|September 28, 2006
Prediction of germline mutations and cancer risk in the Lynch syndromeSining Chen, Wenyi Wang, Shing Lee, et al.Familial Cancer|October 7, 2022
Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?Ryan Matthew Kahn, Muhammad Danyal Ahsan, Eloise Chapman-Davis, et al.BMC Medical Genomics|May 21, 2017
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testingDonavan T Cheng, Meera Prasad, Yvonne Chekaluk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2020
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based ScreeningKenneth Offit, Kaitlyn A Tkachuk, Zsofia K Stadler, et al.Human Molecular Genetics|March 22, 2021
Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genesRosalie Griffin Waller, Robert J Klein, Joseph Vijai, et al.British Journal of Cancer|October 27, 2021
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancerYaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, et al.Cancer|September 17, 2014
Parent decision-making around the genetic testing of children for germline TP53 mutationsMelissa A Alderfer, Kristin Zelley, Robert B Lindell, et al.Pageof 68